August 24, 2026
Mahmoud Elmidany
preprint
The purpose of this study is to explore clinicians’ views, opinions, and professional perspectives regarding psychedelics among practitioners in selected countries in the SWANA region. Interest in psychedelic-assisted therapies has increased internationally, yet there is limited empirical research on how clinicians in SWANA contexts perceive these substances, including their therapeutic...
Alcoholism & Drug Abuse Weekly
August 24, 2026
Gary Enos
Participants in a Phase 2a trial of a single‐dose psychedelic in combination with cognitive‐behavioral therapy (CBT) for alcohol use disorder (AUD) used terms such as “cleansing” and “rebirth” to describe the impact of their study experience. All but two of the study's 10 interviewed participants reported eliminating or reducing drinking over a 12‐week follow‐up, though several described their...
Social Sciences
August 23, 2026
Daniel J. Kruger, Julie Barron, Larry Norris
Psychedelic decriminalization has moved from the margins of drug-policy discourse to a mainstream public health and equity conversation. This community survey reveals that people with psychedelic experience who live in areas that have decriminalized psychedelics report greater benefits of psychedelic decriminalization than adverse outcomes. In decriminalized zones, most (84.0%) participants (N...
Mental Health Weekly
August 21, 2026
Valerie A. Canady
Given the growing interest in psychedelic‐assisted therapies, questions remain about how such services perform outside controlled clinical trials. A new JAMA Network Open study offers an early look at the risks and benefits of Oregon's state‐regulated psilocybin program, which researchers describe as the first study of its kind in the nation.
August 19, 2026
David Engelken, Eva‐lotta Brakemeier, Uwe Herwig et al.
preprint
This qualitative interview study aims to explore the dynamics of psychotherapy and therapeutic touch in Psychedelic Assisted Therapy (PAT). With the increasing use of psychedelic-assisted therapy (PAT), there is a growing demand for manuals and guidelines for therapists on the application of PAT. In order to develop these on an evidence-based basis, studies are needed that examine specific...
Life
August 14, 2026
Szabolcs Kéri
Clinical trials and naturalistic studies describe psychedelics under markedly different exposure conditions. This narrative review searched PubMed/MEDLINE, the Cochrane Library, ClinicalTrials.gov, and regulatory sources through 15 July 2026, and examined safety and outcomes across four dimensions of exposure: dose, frequency, person, and context. In screened adults receiving one to three...
Med
August 14, 2026
Felix Müller, Anna M Becker, Christopher Böhlke et al.
In Basel, only a few hundred meters from where LSD was first synthesized, we tested LSD-assisted therapy for major depression in a randomized trial comparing two high doses with two low doses, each paired with supportive psychotherapy. This Backstory reflects on treating patients, long dosing days, and what remains uncertain.
Journal of Psychoactive Drugs
August 12, 2026
Jennifer S. Jewell, C. James, Joshua C. Black
There is still inconsistency in psychedelic research across the United States. There are gaps in our understanding of the psychedelic community's perception of topics including reasons for use and set/setting. The goal is to utilize these findings to produce better quantitative research, to ask the right questions of the right communities. This qualitative study organized focus groups from...
bioRxiv (Cold Spring Harbor Laboratory)
August 12, 2026
Orr Shahar, Perettz Golding, Masha Chaykin et al.
preprint
Abstract Post-traumatic stress disorder (PTSD) is a highly prevalent, debilitating psychiatric condition. Existing treatments are ineffective for many patients. 3,4- methylenedioxymethamphetamine (MDMA)-assisted psychotherapy has demonstrated substantial clinical efficacy but relies on prolonged, resource-intensive therapeutic protocols that limit scalability and accessibility. Here, we...
Recherche en soins infirmiers
August 11, 2026
Juliette Gavoury, Romain Perot
INTRODUCTION: Psychedelic-assisted psychotherapy (PAP) is emerging as a promising approach for treating various treatmentresistant psychiatric disorders. Despite the expansion of this practice, few studies have examined nursing contribution. OBJECTIVES: This review explores nursing contributions to PAP in psychiatry and analyzes the challenges related to nurses’ contributions. METHOD: A scoping...